Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized Double-blind Study of Adjuvant Pembrolizumab With or Without V940 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy (INTerpath-009)
INTERVENTIONAL
Inicio: 21 de oct de 2024
ID: NCT06623422
Desconocido
ClinicalTrials.gov
Prevalence of Respiratory Aspiration in Patients With COPD: Cross-sectional Study
INTERVENTIONAL
Inicio: 1 de jun de 2016
ID: NCT02722629
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Multicenter, Randomized Study to Compare the Efficacy and Safety of MK-7684A or MK-7684A Plus Docetaxel Versus Docetaxel Monotherapy in the Treatment of Participants With Metastatic Non-small Cell Lung Cancer With Progressive Disease After Treatment With a Platinum Doublet Chemotherapy and Immunotherapy
INTERVENTIONAL
Inicio: 20 de abr de 2021
ID: NCT04725188
Completado
Fase 3
ClinicalTrials.gov
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
INTERVENTIONAL
Inicio: 26 de jun de 2012
ID: NCT01560624
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Open-label, Randomized Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Patients With EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer After Progression on Osimertinib and Chemotherapy
INTERVENTIONAL
Inicio: 5 de ago de 2022
ID: NCT05388669
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Open-Label, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) in Combination With Carboplatin+Paclitaxel or Atezolizumab in Combination With Carboplatin+Nab-Paclitaxel Versus Carboplatin+Nab-Paclitaxel in Chemotherapy-Naive Patients With Stage IV Squamous Non-Small Cell Lung Cancer
INTERVENTIONAL
Inicio: 11 de jun de 2015
ID: NCT02367794
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01238861
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Parallel Group Study to Assess the Efficacy and Safety of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (2.5 µg / 5 µg; 5 µg / 5 µg) (Delivered by the Respimat® Inhaler) Compared With the Individual Components (2.5 µg and 5 µg Tiotropium, 5 µg Olodaterol) (Delivered by the Respimat® Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD). [TOnado TM 1]
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01431274
Completado
Fase 3
ClinicalTrials.gov
A Double Blind, Randomized, Phase II-III Maintenance Study of SR48692 Versus Placebo in Patients With Extensive Stage Small Cell Lung Cancer Following a First Line Chemotherapy With Cisplatin + Etoposide
INTERVENTIONAL
Inicio: 1 de oct de 2002
ID: NCT00290953
Completado
Fase 3
ClinicalTrials.gov
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Existing Asthma Therapy in Patients With Uncontrolled Severe Asthma.
INTERVENTIONAL
Inicio: 11 de dic de 2015
ID: NCT02555683
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Efficacy And Safety Study Of Monotherapy Sitaxsentan Sodium Versus Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension Who Have Completed Study B1321001 (NCT00795639)
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00796666
Completado
Fase 3
ClinicalTrials.gov
Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology
INTERVENTIONAL
Inicio: 1 de sept de 2008
ID: NCT00686959
Completado
Fase 2
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Dose-finding Study Evaluating Efficacy, Safety, and Tolerability of Different Oral Doses of BI 1819479 Over at Least 24 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)
INTERVENTIONAL
Inicio: 5 de sept de 2024
ID: NCT06335303
Reclutando
ClinicalTrials.gov
Clinical Trial in Hypertensive Patients Comparing Two Cardiorespiratory Exercise Protocols, Low-volume Sprint Interval Training (SIT) Versus Moderate-intensity Continuous Training (MICT), to Evaluate Decreases in Ambulatory Blood Pressure and Other Clinical Variables.
INTERVENTIONAL
Inicio: 29 de abr de 2025
ID: NCT07229196
Completado
Fase 4
ClinicalTrials.gov
A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis
INTERVENTIONAL
Inicio: 1 de ene de 2012
ID: NCT01519661
Terminado
Fase 3
ClinicalTrials.gov
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
INTERVENTIONAL
Inicio: 1 de nov de 2013
ID: NCT01947946
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate the Safety and Efficacy of Intravenous to Oral Delafloxacin in Adult Subjects With Community-Acquired Bacterial Pneumonia
INTERVENTIONAL
Inicio: 14 de dic de 2016
ID: NCT02679573
Reclutando
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial Evaluating the Efficacy and Safety of 2 Doses of Buloxibutid Over 52 Weeks in People With Idiopathic Pulmonary Fibrosis.
INTERVENTIONAL
Inicio: 9 de dic de 2024
ID: NCT06588686
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C (CodeBreaK 202)
INTERVENTIONAL
Inicio: 16 de nov de 2023
ID: NCT05920356
Activo, no recluta
ClinicalTrials.gov
Assessment of Children and Adolescents With Asthma: An Observational Prospective Study
OBSERVATIONAL
Inicio: 26 de jul de 2017
ID: NCT04480242
Anterior
1
...
33
34
35
...
434
Siguiente
Filtros